CORUM Group (COO) Chair, Nick England, is set to take on the role of interim CEO, following the resignation of CEO, Julian Sallabank.
Sallabank has left the company to resume his former role as Managing Director of the Tegman Medical Research Impact Fund.
England thanked Sallabank for his service to the company.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Feb 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Feb 22
